SkyCell and Korean Air form transportation partnership
Cold-chain deal strives to contribute to vaccine distribution efforts
SkyCell, a manufacturer of data-driven temperature-controlled containers for the pharma industry, has partnered with Korean Air Cargo as it focuses on business development in Korea.
The partnership comes at a time when there is an increase in demand for Covid-19 vaccines and treatments this year. Cold-chain maintenance for vaccine transportation is one of several challenges faced by the global logistics industry—SkyCell and Korean Air are working to help these medicines reach patients in a timely manner.
SkyCell’s hybrid containers allow pharma companies to optimize supply chains using data to predict and control risk. Using over three-quarters of a billion datapoints on factors like temperature, location and time, the company makes note of audited failure rates of less than 0.1%, while reducing carbon dioxide emissions by almost half.
In 2019, Korean Air was awarded the International Air Transport Association (IATA)’s Centre of Excellence for Independent Validators (CEIV) Pharma certification. CEIV Pharma is an international standard that indicates an airline’s ability to manage pharmaceuticals, including the handling procedure, equipment and facilities. More than 280 checklists are evaluated by validators to authorize the certification.
